Pricing Log in Create free account

Electra Therapeutics Inc. (ETRA) vs Iambic Therapeutics, Inc. (IAM)

Electra Therapeutics Inc. and Iambic Therapeutics, Inc. are both Biotechnology companies. Iambic Therapeutics, Inc. is the larger, with a market value of $634.2M against $515.9M — 1.2× the size.

Valuation

Metric ETRA IAM Biotechnology median
P/E — — 10.85
P/S — — 9.49
P/B — — 2.18
Price to free cash flow — — 25.85
EV/EBITDA — — 0.70
EV/Sales — — 8.99
Earnings yield — — (31.76%)
Free cash flow yield — — (21.84%)

Profitability

Metric ETRA IAM Biotechnology median
Gross margin — — 68.51%
Operating margin — — 0.00%
Net margin — — 0.00%
Free cash flow margin — — 0.00%
Return on equity — — (50.82%)
Return on assets — — (46.04%)
Return on invested capital — — 0.00%

Growth

Metric ETRA IAM Biotechnology median
Revenue growth (TTM) — — 6.96%
EPS growth (last fiscal year) — — 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric ETRA IAM Biotechnology median
Debt to equity — — 0.00
Current ratio — — 4.84
Net debt to EBITDA — — 1.01

Dividend

Metric ETRA IAM Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric ETRA IAM Biotechnology median
Market cap 515.94m 634.23m 163.56m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack